FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2090908133> ?p ?o ?g. }

• W2090908133 endingPage "563" @default.
• W2090908133 startingPage "556" @default.
• W2090908133 abstract "Aim: To evaluate the potential advantages of a constant overnight subcutaneous delivery of insulin in type 2 diabetic patients who fail to achieve glycaemic control on oral antidiabetics. Methods: Ten type 2 diabetic patients treated with oral antidiabetic drugs without gaining sufficient glycaemic control were included in this three-period study. All patients received continuous subcutaneous insulin infusion (CSII) with a short-acting insulin analogue, 2 IU/h, for 8 h during three consecutive nights (period A). Based upon the results from period A, two additional dose regimens of three nights (period B and C) were studied in random order. Serum insulin aspart, human insulin and plasma glucose (PG) profiles were recorded. Results: In period A, fasting plasma glucose (FPG) was reduced from a mean ± s.d. (mmol/l) value of 11.6 ± 2.9 to 5.5 ± 1.6 (p < 0.0001) during the first night. No additional lowering of FPG was seen the two succeeding nights. FPG narrowed as the range before the infusion was 7.3–15.2 mmol/l compared with 3.6–6.1 mmol/l on the last morning after infusion. The variability in PG profile during the first and the last night of CSII was small and not significantly different. The rising insulin aspart was mirrored by a decrease in human insulin. In period B and C, similar tendencies as for period A were seen. In period A, two patients each experienced one mild hypoglycaemic episode. Conclusions: CSII with an insulin analogue overnight effectively reduced FPG without occurrence of major hypoglycaemia in type 2 diabetic patients who fail to achieve glycaemic control on oral antidiabetic treatment." @default.
• W2090908133 created "2016-06-24" @default.
• W2090908133 creator A5014622794 @default.
• W2090908133 creator A5018404584 @default.
• W2090908133 creator A5024365002 @default.
• W2090908133 creator A5032819409 @default.
• W2090908133 creator A5042350110 @default.
• W2090908133 creator A5046901920 @default.
• W2090908133 creator A5066686056 @default.
• W2090908133 creator A5083089296 @default.
• W2090908133 date "2008-07-01" @default.
• W2090908133 modified "2023-09-26" @default.
• W2090908133 title "Overnight CSII as supplement to oral antidiabetic drugs in Type 2 diabetes" @default.
• W2090908133 cites W1964413807 @default.
• W2090908133 cites W1964773646 @default.
• W2090908133 cites W1965722550 @default.
• W2090908133 cites W1968703488 @default.
• W2090908133 cites W1981978041 @default.
• W2090908133 cites W1988535925 @default.
• W2090908133 cites W1991835641 @default.
• W2090908133 cites W1995174276 @default.
• W2090908133 cites W1996441843 @default.
• W2090908133 cites W2005775898 @default.
• W2090908133 cites W2032666450 @default.
• W2090908133 cites W2040541826 @default.
• W2090908133 cites W2040746407 @default.
• W2090908133 cites W2045262199 @default.
• W2090908133 cites W2054691668 @default.
• W2090908133 cites W2063701353 @default.
• W2090908133 cites W2065690835 @default.
• W2090908133 cites W2066186289 @default.
• W2090908133 cites W2068252820 @default.
• W2090908133 cites W2071173797 @default.
• W2090908133 cites W2077103544 @default.
• W2090908133 cites W2086438882 @default.
• W2090908133 cites W2091030955 @default.
• W2090908133 cites W2105346472 @default.
• W2090908133 cites W2108753332 @default.
• W2090908133 cites W2123946565 @default.
• W2090908133 cites W2126781806 @default.
• W2090908133 cites W2136164787 @default.
• W2090908133 cites W2149194615 @default.
• W2090908133 cites W2158144637 @default.
• W2090908133 cites W2188846692 @default.
• W2090908133 cites W2337454357 @default.
• W2090908133 cites W3109617681 @default.
• W2090908133 cites W4213149640 @default.
• W2090908133 cites W4253869215 @default.
• W2090908133 doi "https://doi.org/10.1111/j.1463-1326.2007.00748.x" @default.
• W2090908133 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17593233" @default.
• W2090908133 hasPublicationYear "2008" @default.
• W2090908133 type Work @default.
• W2090908133 sameAs 2090908133 @default.
• W2090908133 citedByCount "11" @default.
• W2090908133 countsByYear W20909081332013 @default.
• W2090908133 countsByYear W20909081332014 @default.
• W2090908133 countsByYear W20909081332015 @default.
• W2090908133 countsByYear W20909081332020 @default.
• W2090908133 crossrefType "journal-article" @default.
• W2090908133 hasAuthorship W2090908133A5014622794 @default.
• W2090908133 hasAuthorship W2090908133A5018404584 @default.
• W2090908133 hasAuthorship W2090908133A5024365002 @default.
• W2090908133 hasAuthorship W2090908133A5032819409 @default.
• W2090908133 hasAuthorship W2090908133A5042350110 @default.
• W2090908133 hasAuthorship W2090908133A5046901920 @default.
• W2090908133 hasAuthorship W2090908133A5066686056 @default.
• W2090908133 hasAuthorship W2090908133A5083089296 @default.
• W2090908133 hasConcept C126322002 @default.
• W2090908133 hasConcept C134018914 @default.
• W2090908133 hasConcept C19720800 @default.
• W2090908133 hasConcept C2777180221 @default.
• W2090908133 hasConcept C2778199505 @default.
• W2090908133 hasConcept C2779306644 @default.
• W2090908133 hasConcept C2779908123 @default.
• W2090908133 hasConcept C2779946736 @default.
• W2090908133 hasConcept C2780668416 @default.
• W2090908133 hasConcept C2781232474 @default.
• W2090908133 hasConcept C3020574416 @default.
• W2090908133 hasConcept C555293320 @default.
• W2090908133 hasConcept C71924100 @default.
• W2090908133 hasConceptScore W2090908133C126322002 @default.
• W2090908133 hasConceptScore W2090908133C134018914 @default.
• W2090908133 hasConceptScore W2090908133C19720800 @default.
• W2090908133 hasConceptScore W2090908133C2777180221 @default.
• W2090908133 hasConceptScore W2090908133C2778199505 @default.
• W2090908133 hasConceptScore W2090908133C2779306644 @default.
• W2090908133 hasConceptScore W2090908133C2779908123 @default.
• W2090908133 hasConceptScore W2090908133C2779946736 @default.
• W2090908133 hasConceptScore W2090908133C2780668416 @default.
• W2090908133 hasConceptScore W2090908133C2781232474 @default.
• W2090908133 hasConceptScore W2090908133C3020574416 @default.
• W2090908133 hasConceptScore W2090908133C555293320 @default.
• W2090908133 hasConceptScore W2090908133C71924100 @default.
• W2090908133 hasIssue "7" @default.
• W2090908133 hasLocation W20909081331 @default.
• W2090908133 hasLocation W20909081332 @default.
• W2090908133 hasOpenAccess W2090908133 @default.
• W2090908133 hasPrimaryLocation W20909081331 @default.

• next